This page lists the SEC filings reported by Pharmstandard International S.A..
| Type | Filed | |
|---|---|---|
| 4 | 2017-11-02 | EDGAR |
| 4 | 2017-06-23 | EDGAR |
| 4 | 2016-10-13 | EDGAR |
| 4 | 2016-10-04 | EDGAR |
| 4 | 2016-09-30 | EDGAR |
| 4 | 2016-09-21 | EDGAR |
| 4 | 2016-09-20 | EDGAR |
| 4 | 2016-09-07 | EDGAR |
| 4 | 2016-08-29 | EDGAR |
| 4 | 2016-08-25 | EDGAR |
| 4 | 2016-08-23 | EDGAR |
| 4 | 2016-08-04 | EDGAR |
| 4 | 2016-07-01 | EDGAR |
| 4 | 2016-03-16 | EDGAR |
| 4 | 2014-10-29 | EDGAR |
| 3 | 2014-10-21 | EDGAR |
| 4 | 2014-02-12 | EDGAR |
| 3 | 2014-02-06 | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.